A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

NCT00005783 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Hemoglobin SC Disease
Sickle Cell Anemia

Interventions

DRUG: Recombinant-methionyl human stem cell factor

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)